Find Dihydroergocristine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

72 RELATED EXCIPIENT COMPANIES

145EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 24730-10-7, Dihydroergocristinmesilat, Dihydroergocristine mesilate, 9,10-dihydroergocristine methanesulfonate, Dihydroergocristine methanesulfonate, Mls000069354
Molecular Formula
C36H45N5O8S
Molecular Weight
707.8  g/mol
InChI Key
SPXACGZWWVIDGR-SPZWACKZSA-N
FDA UNII
DS7CL18UAM

Dihydroergocristine
A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position of the molecule.
1 2D Structure

Dihydroergocristine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
2.1.2 InChI
InChI=1S/C35H41N5O5.CH4O3S/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34;1-5(2,3)4/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41);1H3,(H,2,3,4)/t23-,25-,27-,28+,29+,34-,35+;/m1./s1
2.1.3 InChI Key
SPXACGZWWVIDGR-SPZWACKZSA-N
2.1.4 Canonical SMILES
CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O
2.1.5 Isomeric SMILES
CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
DS7CL18UAM
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Diertine

2. Dihydroergocristine

3. Dihydroergocristine Monomesylate

4. Enirant

5. Ergodavur

6. Mesylate, Dihydroergocristine

7. Monomesylate, Dihydroergocristine

2.3.2 Depositor-Supplied Synonyms

1. 24730-10-7

2. Dihydroergocristinmesilat

3. Dihydroergocristine Mesilate

4. 9,10-dihydroergocristine Methanesulfonate

5. Dihydroergocristine Methanesulfonate

6. Mls000069354

7. Ds7cl18uam

8. Smr000058240

9. Chebi:31490

10. (6ar,9r,10ar)-n-[(1s,2s,4r,7s)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic Acid

11. 5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione Monomethanesulphonate

12. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,10alpha)-, Methanesulfonate (1:1)

13. Dihydroergocristine (mesylate)

14. Unii-ds7cl18uam

15. Sr-01000075381

16. Dihydroergocristinmesilat [german]

17. Diertine (tn)

18. Prestwick_745

19. Einecs 246-434-6

20. Dihydroergocristine Methanesulfonate Salt

21. Ergocristine, Dihydro-, Methanesulfonate

22. Oxamide Methanesulfonate

23. Opera_id_1422

24. Mls001076298

25. Mls001333686

26. Mls002222256

27. Schembl178144

28. Dihydroergocristine Monomesylate

29. Cid_444034

30. Chembl1255837

31. Bdbm30706

32. Dtxsid20872322

33. Ergocristine, 9,10-dihydro-, Monomethanesulfonate (salt)

34. 9,10-dihydroergocristine Mesilate

35. 9,10-dihydroergocristine Mesylate

36. C35h41n5o5.ch3so3h

37. Hms1569b06

38. Hms2096b06

39. Hms2233k22

40. Hms3411o07

41. Hms3675o07

42. Dihydroergocristine Mesilate (ban)

43. Hy-n2319

44. Mfcd00153792

45. Akos024458318

46. Ccg-208194

47. Ncgc00025380-03

48. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'.alpha.,10.alpha.)-, Monomethanesulfonate (salt)

49. Ergotamane-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'-alpha,10-alpha)-, Monomethanesulfonate (salt)

50. Dihydroergocristine Mesilate [mart.]

51. Dihydroergocristine Mesylate [vandf]

52. Cs-0020631

53. D-155

54. Dihydroergocristine Mesilate [who-dd]

55. Eu-0100409

56. Mls000069354-02

57. D07833

58. Dihydroergocristine Methanesulfonate [mi]

59. 9,10-dihydroergocristine Methanesulphonate

60. Dihydroergocristine Mesilate [ep Monograph]

61. Sr-01000000009

62. J-015650

63. Sr-01000000009-2

64. Sr-01000075381-1

65. Q27114325

66. Dihydroergocristine Mesilate, European Pharmacopoeia (ep) Reference Standard

67. (10alphah)-5'alpha-benzyl-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)-9,10-dihydroergotaman Methanesulfonate

68. (5'?,10?)-9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-trione Mesylate

69. (5'alpha,10alpha)-9,10-dihydro-12'-hydroxy-2'-(1 -methylethyl)-5'-(phenylmethyl)-ergotaman-3',6',18-tr Ione Mesylate

70. (6ar,9r,10ar)-n-((2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-isopropyl-3,6-dioxooctahydro-2h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carb

71. (6ar,9r,10ar)-n-((2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-isopropyl-3,6-dioxooctahydro-2h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide Methanesulfonate

72. (6ar,9r,10ar)-n-[(2r,5s,10as,10bs)-5-benzyl-10b-hydroxy-2-(1-methylethyl)-3,6-dioxo-octahydro-8h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline

73. 5'.alpha.-benzyl-9,10.alpha.-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione Monomethanesulphonate

74. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'.alpha.,10.alpha.)-, Monomethanesulphonate (salt)

75. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,10alpha)-, Monomethanesulfonate (salt)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 707.8 g/mol
Molecular Formula C36H45N5O8S
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count5
Exact Mass707.29888458 g/mol
Monoisotopic Mass707.29888458 g/mol
Topological Polar Surface Area181 Ų
Heavy Atom Count50
Formal Charge0
Complexity1300
Isotope Atom Count0
Defined Atom Stereocenter Count7
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Adrenergic Antagonists

Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE. (See all compounds classified as Adrenergic Antagonists.)


Related Excipient Companies

Upload your portfolio for free, ask us